VP8, the Major Tegument Protein of Bovine Herpesvirus-1, Is Partially Packaged during Early Tegument Formation in a VP22-Dependent Manner. [PDF]
Sucharita S +2 more
europepmc +1 more source
Evolution of Bovine Herpesvirus-1 infection prevalence and infection dynamics in Irish dairy herds following an IBR hyperimmunisation vaccination protocol. [PDF]
Duffy R +10 more
europepmc +1 more source
Oncolytic Bovine Herpesvirus 1 Inhibits Human Lung Adenocarcinoma A549 Cell Proliferation and Tumor Growth by Inducing DNA Damage. [PDF]
Qiu W, Ding X, Li S, He Y, Zhu L.
europepmc +1 more source
Seroprevalence to bovine herpesvirus type 1 in sheep in Turkey.
Uzorci seruma 1146 ovaca s osam različitih mjesta u sjevernom području Turske bili su pretraženi na goveđi herpesvirus 1 (GHV-1) uobičajenim serum neutralizacijskim testom. Specifična protutijela za GHV-1 dokazana su u 1,74% (20/1146) ovaca.
Yazici, Zafer +5 more
core
Transcriptional profiles of vaccine-induced protection in bovine herpesvirus-1 and <i>Mycoplasma bovis</i>-challenged bison. [PDF]
Goldkamp AK +10 more
europepmc +1 more source
Infection with bovine herpesvirus 1 (BHV 1) occurs worldwide and causes serious economic losses due to loss of animals, abortions, decreased milk production, and loss of body weight.
core +1 more source
A bivalent subunit bovine herpesvirus 1 vaccine based on the ectodomains of glycoproteins D and B elicits robust protective immunity against infection in a rabbit model. [PDF]
Liu W +11 more
europepmc +1 more source
Seroepidemiology of bovine herpesvirus-1 in goats in south-western Iran. [PDF]
Pourmahdi Borujeni M +3 more
europepmc +1 more source
First report of histopathological and molecular characterizations of bovine herpesvirus-1 from outbreak at dairy farm in India. [PDF]
Verma AK +4 more
europepmc +1 more source
Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy. [PDF]
Baracuhy EM +4 more
europepmc +1 more source

